3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
6
Phase EARLY_PHASE1
1
Phase 3
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Motor Activity
6
Skin Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Melanoma
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Carcinoma, Merkel Cell
1
Breast Neoplasms
1
Interventions
fludarabine
1
Transplantation
1
Tablets
1
Stem Cell Transplantation
1
Roflumilast
1
Pemetrexed
1
Nadolol
1
Isoproterenol
1
Introns
1
FANG vaccine
1
Exercise
1
Cyclophosphamide
1
Counseling
1
Cord Blood Stem Cell Transplantation
1
Carvedilol
1
Bortezomib
1
Bisoprolol
1
68Ga-pentixafor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Leukemia
×
Exercise
×
Clear all
NCT06643221
2024-10-16
Allo-X
University of Arizona
Phase EARLY_PHASE1
Recruiting
100 enrolled